Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New cryoprecipitate vs conventional method in obstetric critical hemorrhage
jRCTs032210302Completed
- Sponsor
- Grant-in-Aid for Research Activity Start-up
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of new cryoprecipitate in postpartum hemorrhage (PPH), sponsored by Grant-in-Aid for Research Activity Start-up. Primary endpoint: Difference between measured and predicted fibrinogen values. Started Sep 2021; status: completed.
02
Drugs
new cryoprecipitate
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on jRCTs032210302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs032210302.